Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,960 | 490 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,674 | 121 | $0 (2024) |
| Lilly USA, LLC | $853.45 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $737.84 | 45 | $0 (2024) |
| PFIZER INC. | $493.16 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $440.85 | 33 | $0 (2024) |
| Amgen Inc. | $406.53 | 25 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $321.40 | 23 | $0 (2022) |
| Novo Nordisk Inc | $292.55 | 19 | $0 (2024) |
| Corium, LLC | $259.30 | 7 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $253.53 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,689 | 89 | Lilly USA, LLC ($278.94) |
| 2023 | $2,027 | 121 | ABBVIE INC. ($538.62) |
| 2022 | $2,033 | 136 | Biohaven Pharmaceutical Holding Company Ltd. ($321.40) |
| 2021 | $2,211 | 144 | AbbVie Inc. ($549.06) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: PAIN | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Obesity | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: PAIN | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 389 | 581 | $150,867 | $38,560 |
| 2022 | 9 | 327 | 441 | $114,441 | $30,599 |
| 2021 | 7 | 275 | 396 | $101,986 | $29,774 |
| 2020 | 5 | 110 | 154 | $41,392 | $9,303 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 217 | $65,968 | $15,096 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $27,208 | $8,155 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 67 | $27,135 | $6,612 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 63 | $12,978 | $3,261 | 25.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $7,170 | $2,057 | 28.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $3,912 | $1,726 | 44.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,825 | $753.75 | 41.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $2,208 | $548.94 | 24.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $1,168 | $126.45 | 10.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 30 | 53 | $424.00 | $116.60 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $871.00 | $106.82 | 12.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 154 | $46,816 | $11,040 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $24,665 | $7,621 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 48 | $19,440 | $4,904 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 72 | $14,832 | $3,684 | 24.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 26 | $4,238 | $1,782 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,898 | $762.84 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 12 | $1,500 | $400.77 | 26.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $876.00 | $354.78 | 40.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 22 | $176.00 | $48.66 | 27.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 172 | $52,288 | $14,087 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 54 | 54 | $17,334 | $6,179 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 39 | $15,795 | $4,577 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 52 | $10,712 | $2,809 | 26.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $3,800 | $1,632 | 42.9% |
About Jordan Bailey, NP
Jordan Bailey, NP is a Nurse Practitioner healthcare provider based in Powhatan, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750507372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jordan Bailey, NP has received a total of $7,960 in payments from pharmaceutical and medical device companies, with $1,689 received in 2024. These payments were reported across 490 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,960).
As a Medicare-enrolled provider, Bailey has provided services to 1,101 Medicare beneficiaries, totaling 1,572 services with total Medicare billing of $108,236. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Powhatan, VA
- Active Since 04/18/2007
- Last Updated 11/23/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1750507372
Products in Payments
- VRAYLAR (Drug) $848.05
- NURTEC ODT (Drug) $708.61
- QULIPTA (Drug) $517.52
- XIFAXAN (Drug) $440.85
- UBRELVY (Drug) $308.86
- FARXIGA (Drug) $294.17
- Otezla (Drug) $272.76
- BREZTRI (Drug) $253.01
- MOUNJARO (Drug) $251.54
- EMGALITY (Drug) $239.41
- TRINTELLIX (Drug) $238.78
- Azstarys (Drug) $219.85
- Vascepa (Drug) $198.96
- TOSYMRA (Drug) $157.06
- ELIQUIS (Drug) $154.50
- TRULICITY (Drug) $141.47
- Coala Heart Monitor (Device) $139.94
- NEXLIZET (Drug) $125.00
- TEZSPIRE (Biological) $124.07
- Dayvigo (Drug) $114.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.